AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Cencora, Inc.
XNYS · usd
SIC 5122 · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
FIGI BBG001SB8L89
323.85▲ 2.50 (0.78%)
As of 2026-10-09
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
321.35
Day's Range
318.79 – 325.82
52-Week Range
244.82 – 377.54
Volume
775.0K
Avg Volume
1.2M
Share Statistics
Shares Outstanding
Employees
51.0K
Exchange
XNYS
Listed
1995-04-04
Share count as of July 31, 2026

Cencora, Inc. (COR) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Cencora, Inc. (COR)
What is Cencora, Inc.'s Market Cap?
Cencora, Inc.'s Market Cap is $61.8B, based on as-reported figures from SEC (XBRL) filings.
What is Cencora, Inc.'s Enterprise Value?
Cencora, Inc.'s Enterprise Value is $70.7B, based on as-reported figures from SEC (XBRL) filings.
What is Cencora, Inc.'s Trailing P/E?
Cencora, Inc.'s Trailing P/E is 23.5×, based on as-reported figures from SEC (XBRL) filings.
What is Cencora, Inc.'s Price / Sales?
Cencora, Inc.'s Price / Sales is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Cencora, Inc.'s EV / Revenue?
Cencora, Inc.'s EV / Revenue is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Cencora, Inc.'s EV / EBITDA?
Cencora, Inc.'s EV / EBITDA is 17.3×, based on as-reported figures from SEC (XBRL) filings.
What is Cencora, Inc.'s Revenue (TTM)?
Cencora, Inc.'s Revenue (TTM) is $332.8B, based on as-reported figures from SEC (XBRL) filings.
What is Cencora, Inc.'s Net Income (TTM)?
Cencora, Inc.'s Net Income (TTM) is $2.6B, based on as-reported figures from SEC (XBRL) filings.
What is Cencora, Inc.'s EBITDA?
Cencora, Inc.'s EBITDA is $4.1B, based on as-reported figures from SEC (XBRL) filings.
What is Cencora, Inc.'s Diluted EPS (TTM)?
Cencora, Inc.'s Diluted EPS (TTM) is 13.75, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CORAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+5.1%+3.8%+5.5%+5.9%
Cost of goods sold
Gross profit
% of revenue4.3%4.6%3.6%3.5%
Operating expenses:
Distribution, selling, and administrative
Depreciation
Amortization
Litigation and opioid-related (credit) expenses, net
Acquisition and divestiture-related deal and integration expenses
Restructuring and other expenses, net
Impairment of assets, including goodwill—
Operating income
% of revenue1.3%1.5%0.9%0.0%
Other income, net
Interest expense, net
Income before income taxes
Income tax expense
Net income
% of revenue0.9%2.1%0.7%-0.4%
Net income attributable to noncontrolling interests
Net income attributable to Cencora, Inc.
% of revenue0.9%2.1%0.7%-0.4%
Basic (in usd per share)
Diluted (in usd per share)